Friday, October 2, 2026
ExploreSearch
Finance Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 22, 2026

Crypto News: Pepeto Announces $8.28M Raised While Bitcoin Price Prediction Debate Heats Up Between $0 and $150K Levels

View original at globenewswire.com
Crypto News: Pepeto Announces $8.28M Raised While Bitcoin Price Prediction Debate Heats Up Between $0 and $150K Levels Dubai, UAE, March 22, 2026 (GLOBE NEWSWIRE) -- Pepeto just passed the $8.28M mark, and the project is growing faster than anything the meme coin space has seen this year…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Cryptocurrency is a digital commodity, not a security

    60% confidence

  • Pepeto has the same viral energy Shiba Inu had plus real exchange tools Shiba Inu never built

    60% confidence

  • Bitcoin price will reach $150,000

    60% confidence

  • There will be two interest rate cuts in 2026

    60% confidence

  • Cryptocurrency is a digital commodity, not a security

    60% confidence

  • What Pepeto built is something DeFi has been missing for years. One platform that trades across Ethereum, BNB Chain, and Solana with zero fees, moves tokens between all three chains instantly at no cost, and runs AI that catches scam contracts before they ever reach the user. No one else has shipped all of that in one place before a listing. That is why whale wallets, the same kind that built life changing money buying bitcoin before the rest of the world showed up, are entering the Pepeto presale with serious size.

    60% confidence

  • Bitcoin price target of $150,000 is more reasonable than $0, with many expecting $200,000 before the cycle ends

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com
Crypto News: Pepeto Announces $8.28M Raised While Bitcoin Price Prediction Debate Heats Up Between $0 and $150K Levels — Source | Via News | Finance Via News